本文源自：市场资讯 据交易所数据显示，12月17日，新氧(SY)盘中上涨2.22%，截至23:14，报2.995美元/股，成交27.83万美 元，总市值2.98亿美元。 11月19日，新氧将披露2025财年三季报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实 际披露日期以公司公告为准）。 资料显示，新氧国际公司是一家致力于用科技的方式帮助爱美女性健康变美的公司。创始人成立了新 氧,通过提供透明的信息,改变中国快速增长但不透明的医学美学市场,最终使他们能够建立一个一站式的 平台,用户可以方便地找到优质的服务。 财务数据显示，截至2025年06月30日，新氧收入总额6.76亿人民币，同比减少6.84%；归母净利 润-6917.7万人民币，同比减少2909.0%。 大事提醒： 作者：行情君 ...

Core Viewpoint - New Oxygen (SY) experienced a 5.19% increase in stock price, reaching $4.26 per share, with a total market capitalization of $423 million as of August 25 [1] Financial Performance - As of June 30, 2025, New Oxygen reported total revenue of 676 million RMB, reflecting a year-on-year decrease of 6.84% [1] - The company's net profit attributable to shareholders was -69.18 million RMB, showing a significant year-on-year decline of 2909% [1] Major Events - On August 19, New Oxygen received a maintained "Buy" rating from Haitong International, with the target price raised to $10.30 [1] Company Overview - New Oxygen International is focused on leveraging technology to assist women in enhancing their beauty and health [1] - The founder established New Oxygen to provide transparent information, aiming to transform the rapidly growing yet opaque medical aesthetics market in China [1] - The company seeks to create a one-stop platform for users to easily find quality services [1]

Group 1 - The core viewpoint of the article highlights that Xinyang (SY) experienced a stock price increase of 5.12%, reaching $3.9 per share, with a total market capitalization of $387 million as of August 20 [1] - Financial data indicates that as of June 30, 2025, Xinyang's total revenue was 676 million RMB, representing a year-on-year decrease of 6.84%, while the net profit attributable to shareholders was -69.177 million RMB, reflecting a significant year-on-year decline of 2909% [1] - On August 19, Xinyang received a rating upgrade from Haitong International, maintaining a "Buy" rating and raising the target price to $10.3 [1] Group 2 - Xinyang International is a company focused on leveraging technology to assist women in enhancing their health and beauty [1] - The founder established Xinyang to provide transparent information, aiming to transform the rapidly growing but opaque medical aesthetics market in China, ultimately creating a one-stop platform for users to easily find quality services [1]

Group 1 - The core viewpoint of the article highlights the recent performance of Xinyang (SY), which saw a 2.07% increase in stock price, reaching $3.69 per share, with a total market capitalization of $366 million as of August 19 [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue amounted to 297 million RMB, reflecting a year-on-year decrease of 6.6%, while the net profit attributable to shareholders was -33.138 million RMB, a decline of 56.02% year-on-year [1] - Xinyang is positioned as a technology-driven company aimed at enhancing women's health and beauty, providing a transparent platform in China's rapidly growing but opaque medical aesthetics market [2] Group 2 - A significant event reminder states that Xinyang is scheduled to disclose its fiscal year 2025 mid-term report on August 15, prior to the market opening [2] - The company was founded to transform the medical aesthetics market by offering transparent information, ultimately creating a one-stop platform for users to easily find quality services [2]

Group 1 - The core viewpoint of the article highlights that Xinyang (SY) experienced a stock price increase of 2.08% on August 13, closing at $4.91 per share, with a total market capitalization of $492 million [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue amounted to 297 million RMB, reflecting a year-on-year decrease of 6.6%, while the net profit attributable to shareholders was -33.138 million RMB, a decline of 56.02% year-on-year [1] - Xinyang is set to disclose its fiscal year 2025 mid-term report on August 15, prior to the market opening in the Eastern Time Zone [2] Group 2 - Xinyang International Company focuses on leveraging technology to assist women in enhancing their health and beauty [2] - The founder established Xinyang to provide transparent information, aiming to transform the rapidly growing yet opaque medical aesthetics market in China [2] - The ultimate goal is to create a one-stop platform where users can conveniently find high-quality services [2]

Group 1 - The core viewpoint of the article highlights the recent stock performance of Xinyang (SY), which saw a 10.19% increase, reaching $4.76 per share, with a total market capitalization of $477 million as of August 4 [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue was 297 million RMB, reflecting a year-on-year decrease of 6.6%, while the net profit attributable to shareholders was -33.138 million RMB, a decline of 56.02% year-on-year [1] Group 2 - A significant event reminder is noted for August 15, when Xinyang is scheduled to disclose its fiscal year 2025 mid-term report before the market opens (Eastern Time) [2] - Xinyang International Company is described as a firm focused on leveraging technology to assist women in enhancing their beauty and health, aiming to transform the opaque medical aesthetics market in China into a transparent one, ultimately creating a one-stop platform for users to find quality services [2]

Group 1 - The stock price of Xinyang (SY) increased by 8.91% on August 4, closing at $4.705 per share, with a total trading volume of $1.2899 million and a market capitalization of $472 million [1] - As of March 31, 2025, Xinyang reported total revenue of 297 million RMB, a year-on-year decrease of 6.6%, and a net profit attributable to shareholders of -33.138 million RMB, representing a year-on-year decrease of 56.02% [1] Group 2 - Xinyang is scheduled to release its fiscal year 2025 mid-term report on August 15, before the market opens (Eastern Time) [2] - Xinyang International Company aims to leverage technology to assist women in enhancing their health and beauty, providing transparent information to transform the rapidly growing but opaque medical aesthetics market in China [2]

Group 1 - The core viewpoint of the article highlights the recent performance of Xinyang (SY), with a stock price increase of 2.17% to $5.17 per share and a total market capitalization of $518 million as of July 29 [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue was 297 million RMB, reflecting a year-on-year decrease of 6.6%, while the net profit attributable to the parent company was -33.138 million RMB, a significant decline of 56.02% year-on-year [1] - Xinyang is set to release its fiscal year 2025 mid-term report on August 15, with the actual disclosure date subject to company announcements [2] Group 2 - Xinyang International Company focuses on leveraging technology to assist women in enhancing their beauty and health, aiming to transform the opaque medical aesthetics market in China into a transparent one [2] - The founder established Xinyang to provide transparent information, ultimately creating a one-stop platform for users to easily find quality services in the rapidly growing market [2]